Read about Endologix
in the news

Embrace the evidence.

The Latest:

Endologix Announces 1000 patients treated with the DETOUR™ System.

See Release

All News

Archives

Endologix Announces Completion of Enrollment in the EVAS2 Confirmatory Clinical Study to Evaluate the Nellix EndoVascular Aneurysm Sealing System

Endologix Appoints Tim A. Benner as Chief Commercial Officer

Endologix Adds Jane E. Kiernan to its Board of Directors

Endologix Receives FDA Approval for Alto Abdominal Stent Graft System

Endologix LLC Comments on Recent FDA Update on Type III Endoleaks with AFX® Endovascular AAA System